title: [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
authors.forename: P
authors.initials: P
authors.lastname: Schnider
authors.forename: B
authors.initials: B
authors.lastname: Voller
authors.forename: K
authors.initials: K
authors.lastname: Moraru
authors.forename: E
authors.initials: E
authors.lastname: Auff
mesh_terms: D018726:Anti-Dyskinesia Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001764:Blepharospasm / Q000188:drug therapy; D001905:Botulinum Toxins / Q000494:pharmacology* / Q000627:therapeutic use*; D020821:Dystonic Disorders / Q000188:drug therapy*; D004931:Esophageal Achalasia / Q000188:drug therapy; D006801:Humans; D007273:Injections, Intramuscular; D009069:Movement Disorders / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D014832:Voice Disorders / Q000188:drug therapy
chemical_list: D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins
vernacular_title: Die Botulinumtoxinbehandlung: Vom gefürchteten biologischen Toxin zum Standardmedikament.